Gennex Laboratories closes trading window from July 01, 2026
Gennex Laboratories Limited has closed its trading window from July 01, 2026, until 48 hours after the announcement of its unaudited Q1FY27 results. The move follows SEBI regulations to prevent insider trading. The board meeting date to approve the financial results will be announced later.

*this image is generated using AI for illustrative purposes only.
Gennex Laboratories has closed its trading window for dealing in the company's securities effective July 01, 2026. This measure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders. The restriction is intended to prevent insider trading while the company prepares to release its financial performance data for the recent quarter.
The trading window will remain shut until 48 hours after the public announcement of the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The closure period is standard practice to ensure that sensitive information is not misused ahead of formal disclosures. The specific date for the Board of Directors meeting to approve these results has not yet been finalized and will be informed in due course.
Consequently, all promoters, designated persons, and connected persons have been advised not to trade in the securities of Gennex Laboratories Limited either directly or indirectly during this period. The company has communicated this regulatory compliance to the BSE Limited, The Ahmedabad Stock Exchange Limited, and The Calcutta Stock Exchange Limited to ensure the information is placed on record.
Key Compliance Details
| Detail | Information |
|---|---|
| Regulation | SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| Trading Window Closure | July 01, 2026 |
| Reopening | 48 hours after Q1FY27 results announcement |
| Period Covered | First Quarter ended June 30, 2026 |
| Results Type | Un-audited Standalone and Consolidated |
Historical Stock Returns for Gennex Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -3.12% | -10.37% | -19.53% | -14.30% | +12.00% |
How might the extended trading window closure impact liquidity in Gennex Laboratories' stock until the Q1 results are released?
What market expectations are currently priced into Gennex Laboratories' stock ahead of the upcoming unaudited financial results?
Could the delay in finalizing the Board meeting date signal any underlying complexities in finalizing the Q1 financial data?































